Insider · CIK 0001927121
McClure Matthew W.
Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA
Transactions
10
Companies
1
Filings
5
CIK
0001927121
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-03-01 | ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-02-28 | ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-02-28 | ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-02-28 | ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-02-27 | ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-02-27 | ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-02-27 | ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-09-08 | ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-03-15 | ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-07-07 | ALGSAligos Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
Recent filings
- 4McClure Matthew W.0001610717-24-000124SEC(opens sec.gov)
- 4McClure Matthew W.0001610717-24-000100SEC(opens sec.gov)
- 4McClure Matthew W.0001610717-23-000277SEC(opens sec.gov)
- 4McClure Matthew W.0001567619-23-005257SEC(opens sec.gov)
- 4McClure Matthew W.0001567619-22-013870SEC(opens sec.gov)
Companies
Address
C/O ALIGOS THERAPEUTICS, INC. ONE CORPORATE DR., 2ND FLOOR
SOUTH SAN FRANCISCO, CA, 94080